Valuation -- 5/10
| Company | EV/EBITDA (FY+1) | Fwd P/E | EV/Sales | Div Yield | Mix |
|---|---|---|---|---|---|
| Mosaic (MOS) | ~5.1x | 14.0x | ~0.85x | 3.9% | Phosphate + Potash |
| Nutrien (NTR) | ~8.1x | 14.2x | ~1.7x | 2.9% | Potash + Nitrogen + Retail |
| CF Industries (CF) | ~7.0x | 13.4x | ~3.2x | 2.0% | Pure-play Nitrogen |
| Intrepid Potash (IPI) | ~6.0x | ~22x | ~1.4x | 0.0% | U.S. Potash (small-cap) |
| K+S AG (SDF) | ~5.0x | ~10x | ~0.7x | 3.5% | Potash + Salt (EU) |
| Peer Average (ex-MOS) | ~6.5x | ~15x | ~1.75x | 2.1% | |
| Key Takeaway | MOS trades at a ~25-30% discount to NTR/CF on EV/EBITDA but only modestly cheap vs. K+S (the other troubled commodity name). The discount is justified by 2026 sulfur shock and Brazil drag. NTR is the higher-quality way to own the same theme; MOS is the contrarian leveraged bet on a 2027 inflection. | ||||
| Period | Adj. EBITDA | EV/EBITDA Range | Cycle Context |
|---|---|---|---|
| FY2022 (Peak) | ~$5.5B | 3-4x | Russia-Ukraine spike; market priced commodity peak; multiple compressed |
| FY2023 | $2,761M | 5-7x | Normalizing post-spike; Belarus/Russia disruption persistent |
| FY2024 | $2,202M | 6-8x | Trough year; market began pricing 2025 recovery |
| FY2025A | $2,421M | 5-7x | Modest recovery; potash stabilization, China ban tailwind |
| FY2026E (Current) | ~$2.0-2.2B | ~5.1x | Sulfur shock + Brazil drag; trough multiple on trough earnings |
| Scenario | Probability | FY26E EBITDA | EV/EBITDA | Implied Price | Drivers |
|---|---|---|---|---|---|
| Bull | 25% | $2.8-3.0B | ~7.0x | $35-40 | Sulfur normalizes (Hormuz reopens), China ban extends past Aug 2026, Brazil margin recovery, multiple re-rates to peer avg |
| Base | 50% | $2.0-2.2B | ~5.5x | $23-27 | Sulfur stays elevated through 2026; gradual recovery 2027; Brazil weak; multiple stays at trough |
| Bear | 25% | $1.6-1.8B | ~4.5x | $15-18 | Belarus normalizes (sanctions lifted Mar 2026), sulfur stays high, Brazil losses persist, leverage rises to 2x |
| Probability-Weighted Fair Value | ~$24-27 | Current $23.36 = low end of base case; modest positive skew from China/insider signals | |||
Replacement cost analysis provides the downside guardrail when commodity earnings are depressed. Per dim_5 analysis, MOS's combined phosphate + potash asset base is estimated at ~$15B replacement cost -- well above the current ~$10.7B EV.
- Potash assets (Esterhazy, Belle Plaine, Colonsay): ~13Mt operational capacity. New greenfield potash builds run $4,000-6,000/tonne of capacity = $50-80B replacement. Even at fractional brownfield economics, MOS's potash leg alone is worth $6-8B.
- Phosphate assets (Florida + Louisiana): Integrated rock-to-finished-product complex with rail/water logistics, gypsum stack permits, and reserves. Difficult to replicate given permitting. Estimated $5-7B replacement.
- Brazil distribution + Mosaic Fertilizantes: Distribution backbone (LATAM market #1 position), even at depressed valuations ~$2-3B.
P/Tangible Book ~0.7x confirms the disconnect -- market values the equity below the carrying value of the hard assets. This is a real floor in a Bear case, but not actionable in the near-term (no obvious catalyst forces market to recognize asset value absent a take-private).
Score of 5/10 reflects a balanced setup: deep-discount valuation with real asset-value floor, but earnings impairment and limited near-term catalysts MOS can self-influence.
Why not higher (6-7): EV/EBITDA at 5.1x represents a 25-30% discount to NTR/CF, with P/TBV at 0.7x and a $15B replacement-cost floor providing genuine downside protection. The 3.9% dividend yield (frozen but covered) is competitive. If sulfur normalizes by 2H 2026, the stock could re-rate quickly -- $300-500M in annualized EBITDA recovery from a single quarter of sulfur stabilization. Insider cluster buy at $26.02 in March 2026 (CEO + CFO + CAO) signals management views current price as below intrinsic. China phosphate export ban (food-security framing is durable through August 2026) supports stripping margins. Stock down ~33% from 52-week high creates real contrarian setup.
Why not lower (3-4): P/E of 175x trailing reflects collapsed earnings, not a temporary blip. FY26E EBITDA cut post-Q1 to $2.0-2.2B from prior ~$2.5B. Brazil EBITDA guidance pulled for Q2. Marginal sulfur at $1,200/t is forcing real production curtailments at Bartow and Louisiana. Quality gates fail (FCF negative 3 of 4 last quarters; mgmt 3-yr hit rate ~36%). NTR offers similar fertilizer exposure at 8.1x EV/EBITDA but with retail earnings stability and oligopoly characteristics -- a higher-quality way to own the theme. The path to MOS upside requires geopolitical resolution (Hormuz, China policy) that MOS cannot influence.
Net assessment: MOS is a contrarian commodity inflection trade -- not a quality compounder. Probability-weighted fair value ~$24-27 implies modest upside from current $23.36 with skew favoring Bull (insider signals, China ban, asset floor) over Bear (Belarus normalization, Brazil persistence). Suitable for 1-3% position sizing as contrarian deep-value with a 12-18 month hold horizon. Higher-quality investors should prefer NTR for the same theme.